Results 131 to 140 of about 25,487 (238)

The levels of osteoprotegerin, transforming growth factor-β, and some cytokines in women with coronary heart disease concurrent with severe osteoporosis

Терапевтический архив, 2015
Aim. To determine the serum level of cytokines in women with coronary heart disease (CHD) concurrent with osteoporosis (OP) and in those with isolated CHD; to assess a relationship of the levels of cytokines, osteoprotegerin (OPG), and transforming ...
S Yu Tsarenok, V V Gorbunov
doaj  

Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients [PDF]

, 2020
Background: Osteoprotegerin and osteopontin have recently emerged as key factors in both vascular remodelling and atherosclerosis progression. Interleukin-6 (IL-6) is an inflammatory cytokine with a key role in atherosclerosis.
Charalambous, Georgios, Mourouzis, Oikonomou, Evangelos, Siasos, Gerasimos, Vavuranakis, Manolis, Maniatis, Konstantinos, Paraskevopoulos, Thodoros, Tousoulis, Dimitris, Zaromytidou, Marina, Konstantinos, Papavassiliou, Athanasios G.   +10 more
core  

Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease

Терапевтический архив, 2014
AIM: To study the role of the bone mineral metabolic mediators osteoprotegerin (OPG) and fibroblast growth factor 23 (FGF-23) in the mechanisms of cardiovascular events (CVEs) in chronic kidney disease (CKD)/MATERIAL AND METHODS: Sixty-eight patients (30
F U Dzgoeva, T M Gatagonova, T L Bestaeva, M Iu Sopoev, B G Bazaeva, O V Khamitsaeva   +5 more
doaj  

Diyabetik ayak ülserlerinde solubl Fas/Fas ligand ve osteoprotegerin yolağının rolü [PDF]

, 2013
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Aim: Apoptosis contributes to atherosclerosis. Fas/Fas ligand promotes apoptosis while osteoprotegerin does the reverse.
Taskıran, Bengür, Demir, Ahmet Muzaffer, Tuğrul, Ayşe Armağan, Uğur Altun, Betül, Güldiken, Sibel   +4 more
core  

Might modulation of the endocannabinoid system provide a potential dual therapeutic strategy for osteoporosis and depression?

General Psychiatry, Volume 39, Issue 4, August 2026.
Peng Wei, Pianpian Zhao, Zenghui Gu, Mengyuan Yang, David Karasik, Ching‐Lung Cheung, Houfeng Zheng   +6 more
wiley   +1 more source

The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes [PDF]

Osteoprotegerin is a recently identified inhibitor of bone resorption. Recent studies indicate that osteoprotegerin also acts as an important regulatory molecule in the vasculature.
Xiang, G.
core  

Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. <i>Diagnostics</i> 2026, <i>16</i>, 786. [PDF]

Diagnostics (Basel)
Bednarek AM, Owczarek AJ, Dziadosz D, Olszanecka-Glinianowicz M, Chudek JT.   +4 more
europepmc   +1 more source

Circulating Wnt Signaling Inhibitors and Osteoprotegerin in Women with Newly Diagnosed Overt Thyroid Dysfunction. [PDF]

Metabolites
Miteva MZ, Orbetzova MM, Nonchev BI, Davcheva DM, Gigov K.   +4 more
europepmc   +1 more source

Comparable Protective Effects of Low- and High-Dose MK-7 on Bone Structure and Remodeling in a Rat Model of Osteoporosis Induced by Estrogen Deficiency and Glucocorticoid Exposure. [PDF]

Nutrients
Chiang HJ, Hsu SY, Leu S.
europepmc   +1 more source

Osteoprotegerin [PDF]

, 2017
openaire   +2 more sources